COO might still retest that $45/46 area, I would not be aggressive. When they acquired Occular, I took it out the core, turned out to be for good reasons (huge acquisition, often difficult to swallow, and in this case, wrecked the pristine balance sheet COO enjoyed prior to the acquisition). I think it may base in the $45 to $55 range till fall and trade it accordingly.
Market Data 
Markets 
AI
